Clinical Trial Update: Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing safety and immunogenicity of a live attenuated varicella vaccine in healthy individuals aged 13 and older has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine (varicella vaccine)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Varicella | Phase 3 | Status: COMPLETED